Recurrent miscarriage is associated with increased ghrelin mRNA expression in the endometrium- a case-control study

• Published in: Reproductive biology 2018-03, Vol.18 (1), p.12-17
• Main Authors: Zwierzchowska, Aneta, Iwan, Anna, Hyc, Anna, Suchońska, Barbara, Malejczyk, Jacek, Barcz, Ewa
• Format: Article
• Language: English
• Subjects: Ghrelin; qRT-PCR; Recurrent miscarriage; VEGF
• ISSN: 1642-431X
• DOI: 10.1016/j.repbio.2017.11.003

Ghrelin has been found to be expressed in the human endometrium. Emerging evidence links ghrelin and its receptor with the reproductive system. Certain associations between ghrelin and angiogenesis have also been established. The aim of this small case-control study was to quantify and compare the expression of mRNA encoding ghrelin, ghrelin receptor (GHS-R), vascular endothelial growth factor A (VEGF A) and its receptors (VEGFR1-3) in the endometrium of women with recurrent miscarriage compared to parous controls. Correlations between the expression of particular genes were also investigated. Endometrial samples were obtained during the secretory phase of the menstrual cycle from 15 women with a history of recurrent miscarriage (first trimester pregnancy loss without a known cause) and 10 healthy parous controls. Ghrelin, GHS-R, VEGF A and VEGFR1-3 mRNA expression was analyzed by quantitative RT-PCR. The expression of mRNA for ghrelin and VEGF A was significantly higher in the study group than the control group. In the control group, the expression of ghrelin mRNA was positively correlated with the expression of VEGF A and VEGFR1 mRNA. In the study group, no such associations were observed. These results show that the expression of mRNA for ghrelin and VEGF A may be increased in the endometrium of women with recurrent miscarriage thus suggesting that ghrelin may play a role in the pathogenesis of recurrent miscarriage.